Roledumab
From Wikipedia, the free encyclopedia
Template:Short description Template:Short description Page Template:Infobox drug/styles.css has no content.
Page Module:Infobox/styles.css has no content.
Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1][2]
It is currently at Phase III trials for Rh disease.
References
Page Template:Reflist/styles.css has no content.
- ^ Page Module:Citation/CS1/styles.css has no content.World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
- ^ Page Module:Citation/CS1/styles.css has no content.Kaplon H, Reichert JM (2018). "Antibodies to watch in 2018". mAbs. 10 (2): 183–203. doi:10.1080/19420862.2018.1415671. PMC 5825203. PMID 29300693.